News & Updates

Show Multimedia Only

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025 by

A single dose of adjuvanted respiratory syncytial virus (RSV) prefusion F protein–based vaccine (RSVPreF3 OA) is efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) over three RSV seasons in older adults aged ≥60 years, according to results of the phase III AReSVi-006 trial presented at ESCMID Global 2025.

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

07 May 2025

Single primaquine dose helps block malaria transmission in children

06 May 2025

A single low primaquine dose appears to safely and efficaciously reduce transmission of Plasmodium falciparum in children, according to the results of a meta-analysis.

Single primaquine dose helps block malaria transmission in children

06 May 2025

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

06 May 2025 by

BNT162b2 JN.1-adapted vaccine provides protection against COVID-19–related hospitalization in Europe, a case-control study using the id.DRIVE platform has shown.

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

06 May 2025

More than half of UTIs treated inappropriately in primary care in SG

05 May 2025 by

New research from Singapore has shown that most patients with uncomplicated urinary tract infections (UTIs) being treated in primary care receive inappropriate antibiotics.

More than half of UTIs treated inappropriately in primary care in SG

05 May 2025

Ibrexafungerp expands salvage antifungal treatment options as a pill

03 May 2025 by

For patients with fungal diseases that preclude receiving standard treatment or IV antifungals primarily due to refractoriness or resistance, ibrexafungerp can serve as an effective salvage treatment given orally, offering a positive risk-benefit ratio up to the final data cut-off in the FURI trial

Ibrexafungerp expands salvage antifungal treatment options as a pill

03 May 2025

Breastfeeding reduces risk of infant RTIs

02 May 2025

Infants who have been fully breastfed for 6 months up to at least 1 year appear to have a lower risk of subsequent respiratory tract infections (RTIs) and hospitalization from RTIs, a study has shown.

Breastfeeding reduces risk of infant RTIs

02 May 2025

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025 by

A recent study suggests patients with severe COVID-19 may benefit from human mesenchymal stem cell (MSC) therapy.

MSC therapy delivers long-term benefit in severe COVID-19

02 May 2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

New drug applications approved by US FDA as of 1-15 April 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

02 May 2025

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

01 May 2025

COVID-19 pandemic and pandemic-related events do not appear to have resulted in cognitive decline in middle-aged women, according to a study.

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

01 May 2025

Single-dose baloxavir reduces household transmission of influenza

30 Apr 2025 by

A single dose of baloxavir given to an index patient (IP) reduces the odds of influenza transmission to untreated household contacts (HHCs) by 32 percent vs placebo, according to the results of the phase IIIb CENTERSTONE trial.

Single-dose baloxavir reduces household transmission of influenza

30 Apr 2025

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single-dose RSVPreF3 OA vaccine effective over 3 RSV seasons in seniors

Single primaquine dose helps block malaria transmission in children

Single primaquine dose helps block malaria transmission in children

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

BNT162b2 JN.1-adapted vaccine effective against COVID-19 hospitalization

More than half of UTIs treated inappropriately in primary care in SG

More than half of UTIs treated inappropriately in primary care in SG

Ibrexafungerp expands salvage antifungal treatment options as a pill

Ibrexafungerp expands salvage antifungal treatment options as a pill

Breastfeeding reduces risk of infant RTIs

Breastfeeding reduces risk of infant RTIs

MSC therapy delivers long-term benefit in severe COVID-19

MSC therapy delivers long-term benefit in severe COVID-19

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Original-New-Drug-Application-Approvals-by-US-FDA--1-15-April-2025

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

Cognitive function in middle-aged women not worsened by COVID-19 pandemic

Single-dose baloxavir reduces household transmission of influenza

Single-dose baloxavir reduces household transmission of influenza